Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Clinical trial NCT02307487 · COMPLETED

Trial details

NCT number: NCT02307487
Sponsor: UroGen Pharma Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Neoplasms Urinary Bladder Diseases Urologic Diseases

Start date: 2014-12-01
Primary completion: 2016-04-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.